Transaction · 0001493152-26-041135

Cicala Peter

Cicala Peter, DIR, reported a transaction classified as grant at Ernexa Therapeutics Inc. involving 5083.000000 shares for an estimated $0.00. Reported holdings after the transaction were 5083.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
ERNAErnexa Therapeutics Inc.
Trade date
Aug 31, 2026
Filing date
Sep 02, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded5.08k$0.00 per share
Holdings after5.08kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ERNA price since this filing

Daily closing prices, with the filing date and available return windows
ERNA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -11.7%30d -34.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001493152-26-041135
Stock Option (Right to buy)
Transaction date
Aug 31, 2026
Filed Sep 02, 2026, 01:56 AM · 2d delay
Shares
5,083 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
5,083 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest i…

  2. F2

    Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026,…

Original filing · 0001493152-26-041135
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ERNA